OmniInsight™ for Coronary Artery Disease (OI-CAD™) (PRS + Monogenic)

$1,900.00

A Breakthrough Saliva Genetic Test for Heart Disease Risk

Discover your inherited risk for Coronary Artery Disease (CAD) through an advanced saliva-based genetic test that analyzes both Polygenic Risk Scores (PRS) and Monogenic
Mutations.
Results in 4–8 weeks

Test Highlights:

  • PRS Indication: Coronary Artery Disease (CAD)
  • Monogenic Genes (FH): LDLR, APOB, PCSK9, LDLRAP1
  • Comprehensive Report: Includes your personalized risk score, interpretation, and prevention recommendations
  •  Free Virtual Consultation: One-on-one session with a genetic counselor to explain your results and next steps

Price Includes:
A complete Comprehensive Genomic Risk Test, detailed risk report, virtual counseling for
individuals with above-average or high risk, and a personalized prevention roadmap designed to
help you take proactive steps for your heart health.

Exclusive Access:
Gain access to Avigena’s OmniInsight™ (OI™) Integrated Genomic Intelligence Platform, which combines Monogenic and Polygenic Risk Scores (PRS) with clinical and lifestyle data to deliver a holistic, personalized risk assessment and actionable prevention strategy.

Code: AVI-OI-CAD™ Category:

"Prevent a Heart Attack, Before It Starts."

Simple DNA Saliva Test To Uncover Your Inherited Risk For Coronary Artery Disease

Validated across diverse ancestry and tailored to the Arab and Middle Eastern population

What Is A Polygenic Score?

WHO SHOULD TAKE THIS TEST?

Adults (18-79 years)

Adults (40–79 years)

Special Pediatric Group (Ages 10–18)

Why PRS for CAD Matters

The Polygenic Risk Score (PRS) for CAD is a revolutionary genetic test that helps identify your inherited risk of heart disease, even before traditional risk factors like high cholesterol, diabetes, or high blood pressure appear.

How It Works - Step By Step

Developed by Avigena (USA) and Novo Genomics (Saudi Arabia), and trusted by top U.S.
institutions, this test is tailored for Middle Eastern and Arab women.
Results are ready in 4 to 8 weeks, giving you time to act early and make informed decisions.

Along with your personalized risk report, eligible patients receive a complimentary virtual
session with an Avigena genetic counselor. We’ll explain your results and help you explore
practical steps to reduce your risk.
Ask your doctor about the PRS test for coronary artery disease or contact us to learn more.
Your DNA can guide your prevention.